BTAI BioXcel Therapeutics

Watchlist

1.730
-0.070-3.89%

Close Feb 27 16:00 ET

1.810
+0.080+4.62%

Post 18:54 ET

5.37MMarket Cap-0.05P/E (TTM)

About BioXcel Therapeutics Company

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.

Company Profile

SymbolBTAI

Company NameBioXcel Therapeutics

Listing DateMar 8, 2018

Issue Price11.00

Founded2017

CEODr. Vimal Mehta, PhD

MarketNASDAQ

Employees74

Fiscal Year Ends12-31

Address555 Long Wharf Drive,12th floor

CityNew Haven

ProvinceConnecticut

CountryUnited States of America

Zip Code06511

Phone1-475-238-6837

Websitehttp://www.bioxceltherapeutics.com

Company Executives

Name
Position
Salary

Dr. Vimal Mehta, PhD
Director, Chief Executive Officer and President
4.73M

Dr. Vincent J. O'Neill, M.D.
Executive Vice President, Chief of Product Development and Chief Medical Officer
--

Richard I. Steinhart
Senior Vice President, Chief Financial Officer and Principal Accounting Officer
--

Javier Rodriguez
Senior Vice President, Chief Legal Officer and Corporate Secretary
1.12M

Dr. Frank D. Yocca, PhD
Senior Vice President and Chief Scientific Officer
--

Dr. Peter Mueller,PhD
Chairman of the Board
367.33K

Dr. Rajiv Patni, M.D.
Director
--

Dr. Sandeep Laumas, M.D.
Independent Director
329.83K

Dr. Michal Votruba, M.D.,PhD
Independent Director
307.33K

June Bray
Independent Director
327.33K

David J. Mack
Independent Director
--

Michael Miller
Independent Director
332.33K

BTAI BioXcel Therapeutics

About BioXcel Therapeutics Company

Company Profile

Company Executives

Trending Stocks